NIAGEN BIOSCIENCE, INC. Marketing Expense
NIAGEN BIOSCIENCE, INC. (NAGE) reported Marketing Expense of $3.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingExpense · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. marketing expense for the quarter ending 2026-06-30 was $3.89M, a 52.09% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. marketing expense for the quarter ending 2026-03-31 was $3.52M, a 41.97% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. marketing expense for the quarter ending 2025-12-31 was $3.84M, a 48.91% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. marketing expense for the quarter ending 2025-09-30 was $2.72M, a 40.47% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. marketing expense for fiscal 2025 was $11.59M, a 35.68% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. marketing expense for fiscal 2024 was $8.54M, a 16.04% increase from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. marketing expense for fiscal 2023 was $7.36M.
| Period end | Marketing Expense 3 month | Marketing Expense 6 month | Marketing Expense 9 month | Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.89M 10-Q · filed 2026-08-04 | $7.41M 10-Q · filed 2026-08-04 | $11.25M derived: sum of 3 quarters · filed 2026-08-04 | $13.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.52M 10-Q · filed 2026-05-06 | $7.36M derived: sum of 2 quarters · filed 2026-05-06 | $10.07M derived: sum of 3 quarters · filed 2026-05-06 | $12.63M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $6.56M derived: sum of 2 quarters · filed 2026-03-04 | $9.12M derived: sum of 3 quarters · filed 2026-08-04 | $11.59M 10-K · filed 2026-03-04 |
| 2025-09-30 | $2.72M 10-Q · filed 2025-11-04 | $5.28M derived: sum of 2 quarters · filed 2026-08-04 | $7.75M 10-Q · filed 2025-11-04 | $10.33M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.56M 10-Q · filed 2026-08-04 | $5.04M 10-Q · filed 2026-08-04 | $7.62M derived: sum of 3 quarters · filed 2026-08-04 | $9.55M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.48M 10-Q · filed 2026-05-06 | $5.06M derived: sum of 2 quarters · filed 2026-05-06 | $6.99M derived: sum of 3 quarters · filed 2026-05-06 | $9.11M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.51M derived: sum of 2 quarters · filed 2026-03-04 | $6.63M derived: sum of 3 quarters · filed 2026-03-04 | $8.54M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.94M 10-Q · filed 2025-11-04 | $4.06M derived: sum of 2 quarters · filed 2025-11-04 | $5.97M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $2.12M 10-Q · filed 2025-08-06 | $4.03M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $1.91M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $7.36M 10-K · filed 2025-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |